Impact of highly active antiretroviral therapy on blood pressure in HIV‐infected patients. A prospective study in a cohort of naive patients

@article{Palacios2006ImpactOH,
  title={Impact of highly active antiretroviral therapy on blood pressure in HIV‐infected patients. A prospective study in a cohort of naive patients},
  author={Rosario Palacios and J Trujillo Santos and A. B{\'a}ez Garc{\'i}a and Eva Castells and M Gonz{\'a}lez and Josefa Ruiz and Manuel M{\'a}rquez},
  journal={HIV Medicine},
  year={2006},
  volume={7}
}
To assess the impact of highly active antiretroviral therapy (HAART) on the blood pressure (BP) of naive patients after 1 year of treatment. 
View on Wiley
atarazanas.sci.uma.es
147 Citations
Highly Influential Citations
10
Background Citations
34
Methods Citations
1
Results Citations
10

147 Citations

Citation Type

Citation Type

Effects of HIV status and antiretroviral therapy on blood pressure
TLDR
This study explored the associations among blood pressure, HIV status and two predefined highly active antiretroviral therapy (HAART) regimens: treatment with and without nonnucleoside reverse transcriptase inhibitors (NNRTIs) (NN RTI‐ and non‐NNRTI‐based HAART).
Predictors of glucose metabolism and blood pressure among Ethiopian individuals with HIV/AIDS after one‐year of antiretroviral therapy
TLDR
Assessment of the changes and predictors of glucose metabolism and blood pressure among patients with HIV on ART for 12 months found no change in either glucose metabolism or blood pressure.
PREVALENCE OF CARDIOVASCULAR RISK FACTORS AMONG PERSONS LIVING WITH HIV (PLWHS) ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: A STUDY IN KUMASI SOUTH HOSPITAL
A thesis submitted to the Department of Molecular Medicine, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, in partial fulfillment of the requirements for the degree…
Dyslipidemia in the Setting of HIV Infection and Its Management with Statin Therapy Among a Cohort of HIV-Infected Patients in Washington, DC
of Dissertation vii Table of
Improvement in lipid profiles over 6 years of follow‐up in adults with AIDS and immune reconstitution
The aim of the study was to evaluate long‐term changes in lipids and to assess other coronary heart disease (CHD) risk factors in highly experienced AIDS patients with immune reconstitution, and to…
Cardiac transplantation in HIV-positive patients: are we there yet?
  • B. Jahangiri, H. Haddad
  • Medicine, Political Science
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • 2007
Markers of microbial translocation predict hypertension in HIV‐infected individuals
The aim of the study was to test the hypothesis that microbial translocation, quantified by levels of lipopolysaccharide (LPS) and subsequent monocyte activation [soluble (sCD14)], is associated with…
HIV Infection in the Elderly: Arising Challenges
  • B. Mpondo
  • Medicine
    Journal of aging research
  • 2016
TLDR
The challenges encountered by elderly HIV-infected patients are discussed, both clinical and immunological, in a minireview of patients living with HIV at an advanced age.
Predictors, incidence of hypertension and trajectories of blood pressure during a five year period among HIV-infected and uninfected Rwandan women
A research report submitted to the Faculty of Health Sciences, University of the Witwatersrand in partial fulfilment of the requirements for the degree of Masters of Science In Epidemiology and…
[Premature Atherosclerosis in HIV-Infected Pediatric Patients: Literature Review and Clinical Approach].
TLDR
Human immunodeficiency virus infected children and adolescents are a pediatric group with increased risk of premature cardiovascular disease and the clinical approach is mainly based on efficient treatment of the infection, reduction of the modifiable risk factors and promotion of lifestyle changes.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
HIV infection and cardiovascular disease--is there really a link?
Soon after the introduction of protease inhibitors and nonnucleoside reverse-transcriptase inhibitors for the management of human immunodeficiency virus (HIV) infection, clinicians observed unexpec...
Adverse effects of antiretroviral therapy
Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications.
TLDR
The use of antiretroviral therapy for HIV infection has led to substantial reductions in morbidity and mortality, but long-term success requires therapy to be individualized, carefully balancing toxicities with efficacy and resistance.
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.
TLDR
A study was conducted to evaluate the impact of protease inhibitors on the rates of selected opportunistic processes and mortality in patients with AIDS and found similar results.
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
TLDR
Of specific concern is the fact that use of the NNRTI and PI drug classes (alone and especially in combination), particularly among older subjects with normalized CD4 cell counts and suppressed HIV replication, was associated with a lipid profile known to increase the risk of coronary heart disease.
Elevated Blood Pressure in HIV-Infected Individuals Receiving Highly Active Antiretroviral Therapy
TLDR
The use of NNRTI- or PI-containing HAART is associated with elevation of both SBP and DBP in HIV-infected individuals, and no significant BP changes were noted with patients on regimens containing only nucleoside reverse transcriptase inhibitors (NRTIs).
Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study.
TLDR
An independent association between PI use and hyperglycemia, hyperlipidemia, and lipodystrophy is found that is not explained by the antiviral and therapeutic effect of PIs.
Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Naïve and HIV-Negative Controls: Results from a Norwegian Study of 721 Patients
TLDR
It is concluded that the possible influence of HAART on the prevalence of hypertension appears to be a minor problem, considering the marked drop in mortality following antiretroviral therapy.
Changing patterns of mortality across Europe in patients infected with HIV-1
Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.
TLDR
The majority of studies showed that the use of PIs was associated with increased levels of total cholesterol, triglycerides, and low-density lipoprotein, and the benefits of the currently available PIs should be balanced against the long-term risk of cardiovascular disease.
...
1
2
3
4
...